Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Xgeva

Amgen’s Xgeva delays prostate cancer bone pain

A clinical trial of Amgen Inc’s bone drug, Xgeva, found that it can significantly delay the time it takes for prostate cancer to cause bone pain—a finding the company believes will help boost the drug’s market potential.

Amgen said in December that monthly injections of Xgeva, also known as denosumab, added 4.2 months, compared… Amgen’s Xgeva delays prostate cancer bone pain   



late-stage tumors1 - hemorrhagic inflammation1 - nephrology9 - prostate cancer mortality1 - prostate cancer diagnosis1 - anorexia1 - resistance to treatment1 - johnson and johnson1 - catheter infection1 - prostate symptoms1 - antibiotic resistance1 - uric acid nephropathy1 - pathologic fracture1 - sexual changes1 - fresenius1 - foley catheters1 - urethral stones1 - martius flap1 - end-stage renal failure1 - laser light1 - prostate cancer drug2 - metastatic prostate cancer5 - preterm births1 - pten1 - rrt1 - azoospermia1 - heart damage1 - prostatic calculi1 - myocardial infarction1 - taxotere1 -